Intrinsiqq
Zivo Bioscience Inc. logo

Zivo Bioscience Inc. Insider Trading

ZIVO

⊜ Compare
Last 12 months

Insiders bought 295K on the open market and sold nothing.

Net open-market
+295K
7 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
4 / 0
executives and directors
Last open-market buy
Feb 2026
Feb 27, 2026

Get an email when ZIVO's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Apr 17
    Strome Investment Management LP
    Large holder · bought 100,000 at $2.00
    200K
    21% of stake
  • Feb 27
    Laith L Yaldoo
    Director · bought 1,543 at $9.72
    15K
    0.3% of stake
  • Feb 12
    Strome Group, Inc.
    Large holder · bought 20,000 at $9.77
    195K
    4.4% of stake
  • Feb 10
    Laith L Yaldoo
    Director · bought 2,434 at $10.27
    25K
    0.4% of stake
  • Jan 26
    Alison A Cornell
    Director · bought 11,709 at $8.54
    100K
    4.4% of stake
  • Jan 26
    John Bernard Payne
    President and CEO · bought 11,709 at $8.54
    100K
    148% of stake
  • Jan 14
    Christopher D. Maggiore
    Director · bought 1,766 at $8.49
    15K
    0.3% of stake
  • Jan 14
    Laith L Yaldoo
    Director · bought 1,766 at $8.49
    15K
    0.3% of stake
  • Nov 28, 2025
    Laith L Yaldoo
    Director · bought 2,777 at $9.00
    25K
    0.5% of stake
  • Oct 13, 2025
    Strome Investment Management LP
    Large holder · bought 20,259 at $12.34
    250K
    4.7% of stake
  • Oct 10, 2025
    Laith L Yaldoo
    Director · bought 1,659 at $12.05
    20K
    0.3% of stake
  • Oct 8, 2025
    Christopher D. Maggiore
    Director · bought 23,682 at $12.01
    284K
    4.8% of stake
  • Sep 30, 2025
    Laith L Yaldoo
    Director · bought 15,322 at $15.99
    245K
    2.7% of stake
  • Jun 13, 2025
    Laith L Yaldoo
    Director · bought 3,488 at $14.33
    50K
    0.6% of stake
  • Apr 8, 2025No plan
    Christopher D. Maggiore
    Director · sold 20 at $16.25
    $325
    <0.1% of stake
  • Jan 22, 2025
    Laith L Yaldoo
    Director · bought 10,080 at avg $17.53
    177K
    1.9% of stake
  • Dec 26, 2024
    Mark E Strome
    Large holder · bought 75,000 at $20.19
    $1.51M
    23% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ZIVO, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Biological Products, (No Diagnostic Substances) · Pick stocks to compare with ZIVO

CompareIntrinsic value
ATYRAtyr Pharma Inc.
$6.18-6.79%10
VIVSVivoSim Labs, Inc.
$0.15+8.71%10
AIMAIM ImmunoTech Inc.
$0.16+0.63%15
INMBInmune Bio Inc.
$1.33+0.76%10
SNTISenti Biosciences Inc.
$0.18-0.79%0
CRDFCardiff Oncology Inc.
$0.87+1.03%36
IMAImageneBio, Inc.
$4.10+1.99%10
PROKProKidney Corp
$1.12+4.67%10

Spot a number that looks wrong? Check it in ZIVO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ZIVO

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.